Follow
Lingxin Zhang
Lingxin Zhang
Verified email at mayo.edu
Title
Cited by
Cited by
Year
Enhanced photoluminescence and characterization of multicolor carbon dots using plant soot as a carbon source
M Tan, L Zhang, R Tang, X Song, Y Li, H Wu, Y Wang, G Lv, W Liu, X Ma
Talanta 115, 950-956, 2013
1312013
TREM2 interacts with TDP-43 and mediates microglial neuroprotection against TDP-43-related neurodegeneration
M Xie, YU Liu, S Zhao, L Zhang, DB Bosco, YP Pang, J Zhong, U Sheth, ...
Nature neuroscience 25 (1), 26-38, 2022
622022
CYP2C9 and CYP2C19: Deep Mutational Scanning and Functional Characterization of Genomic Missense Variants
L Zhang, V Sarangi, I Moon, J Yu, D Liu, S Devarajan, JM Reid, KR Kalari, ...
Clinical and translational science 13 (4), 727-742, 2020
392020
Ketamine and active ketamine metabolites regulate STAT3 and the type I interferon pathway in human microglia: molecular mechanisms linked to the antidepressant effects of ketamine
MF Ho, C Zhang, L Zhang, H Li, RM Weinshilboum
Frontiers in Pharmacology 10, 1302, 2019
372019
Atorvastatin inhibits CXCR7 induction to reduce macrophage migration
W Ma, Y Liu, C Wang, L Zhang, L Crocker, J Shen
Biochemical Pharmacology 89 (1), 99-108, 2014
332014
ERICH3: vesicular association and antidepressant treatment response
D Liu, Y Zhuang, L Zhang, H Gao, D Neavin, T Carrillo-Roa, Y Wang, J Yu, ...
Molecular psychiatry 26 (6), 2415-2428, 2021
262021
TSPAN5 influences serotonin and kynurenine: pharmacogenomic mechanisms related to alcohol use disorder and acamprosate treatment response
MF Ho, C Zhang, L Zhang, L Wei, Y Zhou, I Moon, JR Geske, DS Choi, ...
Molecular psychiatry 26 (7), 3122-3133, 2021
202021
SLCO1B1: application and limitations of deep mutational scanning for genomic missense variant function
L Zhang, V Sarangi, MF Ho, I Moon, KR Kalari, L Wang, ...
Drug Metabolism and Disposition 49 (5), 395-404, 2021
202021
Dual roles for the TSPYL family in mediating serotonin transport and the metabolism of selective serotonin reuptake inhibitors in patients with major depressive disorder
S Qin, AR Eugene, D Liu, L Zhang, D Neavin, JM Biernacka, J Yu, ...
Clinical Pharmacology & Therapeutics 107 (3), 662-670, 2020
132020
Purinergic P2Y2 Receptor Control of Tissue Factor Transcription in Human Coronary Artery Endothelial Cells: NEW AP-1 TRANSCRIPTION FACTOR SITE AND NEGATIVE REGULATOR*♦
Y Liu, L Zhang, C Wang, S Roy, J Shen
Journal of Biological Chemistry 291 (4), 1553-1563, 2016
122016
Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel Pharmacogenomics
JA Morales-Rosado, K Goel, L Zhang, A Åkerblom, S Baheti, JL Black, ...
Cardiovascular drugs and therapy 35, 549-559, 2021
82021
Genetic variants associated with acamprosate treatment response in alcohol use disorder patients: A multiple omics study
MF Ho, C Zhang, L Wei, L Zhang, I Moon, JR Geske, MK Skime, DS Choi, ...
British journal of pharmacology 179 (13), 3330-3345, 2022
62022
ACE2 and TMPRSS2 SARS-CoV-2 infectivity genes: deep mutational scanning and characterization of missense variants
L Zhang, V Sarangi, D Liu, MF Ho, AR Grassi, L Wei, I Moon, RA Vierkant, ...
Human molecular genetics 31 (24), 4183-4192, 2022
52022
Glucocorticoids unmask silent non-coding genetic risk variants for common diseases
TTL Nguyen, H Gao, D Liu, TJ Philips, Z Ye, JH Lee, G Shi, K Copenhaver, ...
Nucleic acids research 50 (20), 11635-11653, 2022
52022
Role of the purinergic P2Y2 receptor in hippocampal function in mice
A Alhowail, LX Zhang, M Buabeid, JZ Shen, V Suppiramaniam
European review for medical and pharmacological sciences 24 (22), 11858, 2020
52020
TSPAN5, an alcohol responsive gene that alters serotonin levels in human induced pluripotent stem cells: novel molecular links to alcohol use disorder
MF Ho, L Zhang, I Moon, M Skime, AMC Ho, DS Choi, JM Biernacka, ...
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH 43, 223A-223A, 2019
42019
Purinergic Control of Tissue Factor Transcription in Human Coronary Artery Endothelial Cells: New AP-1 Site and Negative Regulator
Y Liu, L Zhang, C Wang, S Roy, J Shen
Arteriosclerosis, Thrombosis, and Vascular Biology 35 (suppl_1), A190-A190, 2015
12015
Targeting MTAP creates a therapeutic vulnerability to PARP inhibition in brain metastatic TNBC by disrupting MAT2A mediated methionine metabolism
Z Lou, X Zeng, F Zhao, L Zhang, RM Weinshilboum, K Tao
2023
Glucocorticoids mediate transcriptome‐wide alternative polyadenylation: Potential mechanistic and clinical implications
TTL Nguyen, D Liu, H Gao, Z Ye, JH Lee, L Wei, J Yu, L Zhang, L Wang, ...
Clinical and translational science 15 (11), 2758-2771, 2022
2022
Glucocorticoids Mediate Transcriptome-wide Alternative Polyadenylation: Mechanisms and Functional Implications
TT Le Nguyen, D Liu, H Gao, Z Ye, JH Lee, L Wei, J Yu, L Zhang, L Wang, ...
bioRxiv, 2022.03. 30.486468, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20